Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
1584 studies found for:    cancer | bevacizumab
Show Display Options
Rank Status Study
21 Recruiting An Exploratory Study of Treatment Sensitivity and Prognostic Factors in a Efficacy and Safety Study of mFOLFOX6 + Bevacizumab Versus. mFOLFOX6 + Panitumumab Therapy in Patients With Chemotherapy-naïve Unresectable Advanced or Recurrent Colorectal Cancer.
Condition: Colorectal Cancer
Interventions: Drug: oxaliplatin (OXA), levofolinate calcium (l-LV), 5-FU, panitumumab;   Drug: oxaliplatin (OXA), levofolinate calcium (l-LV), 5-FU, bevacizumab
22 Completed Bevacizumab and Doxorubicin Hydrochloride Liposome in Treating Women With Locally Recurrent or Metastatic Breast Cancer
Condition: Breast Cancer
Interventions: Drug: bevacizumab + doxorubin hydrochloride liposme;   Drug: Bevacizumab
23 Completed
Has Results
Satraplatin and Bevacizumab in Treating Patients With Metastatic Prostate Cancer Previously Treated With Docetaxel
Condition: Prostate Cancer
Interventions: Biological: bevacizumab;   Drug: satraplatin
24 Completed Bendamustine and Bevacizumab for Advanced Cancers
Condition: Advanced Cancer
Interventions: Drug: Bendamustine;   Drug: Bevacizumab
25 Completed
Has Results
Treatment of Prostate Cancer With Adjuvant Bevacizumab Plus Erlotinib
Condition: Prostate Cancer
Intervention: Drug: Erlotinib + Bevacizumab
26 Completed Study of Combined RHUMAB VEGF and Capecitabine-based Chemoradiation for Patients With Locally Advanced Pancreatic Cancer
Condition: Pancreatic Cancer
Interventions: Drug: Bevacizumab;   Drug: Capecitabine;   Radiation: Radiotherapy
27 Completed First Line Ovarian Cancer Treatment - Cohort Study
Condition: Epithelial Ovarian Cancer
Intervention: Drug: Bevacizumab
28 Recruiting Bevacizumab and Trabectedin +/- Carboplatin in Advanced Ovarian Cancer
Condition: Ovarian Epithelial Cancer Recurrent
Interventions: Drug: bevacizumab and trabectedin;   Drug: bevacizumab, trabectedin and carboplatin
29 Completed
Has Results
Study of Biweekly Capecitabine Dosing With Bevacizumab for the Treatment of Metastatic Breast Cancer Based Upon the Norton-Simon Mathematical Model
Condition: Breast Cancer
Interventions: Drug: Capecitabine;   Drug: Bevacizumab
30 Recruiting Carboplatin-Paclitaxel ± Bevacizumab in Advanced (Stage III-IV) or Recurrent Endometrial Cancer
Condition: Stage III-IV or Recurrent Endometrial Cancer
Interventions: Drug: Bevacizumab;   Drug: Carboplatin AUC 5+Paclitaxel 175 mg/mq q 21 for 6-8 cycles
31 Recruiting Niraparib Versus Niraparib-bevacizumab Combination in Women With Platinum-sensitive Epithelial Ovarian Cancer
Condition: Ovarian Cancer
Interventions: Drug: Niraparib;   Drug: Bevacizumab
32 Recruiting Bevacizumab-containing Regimen for Metastatic Colorectal Cancer Failed to Cytotoxic Treatment
Conditions: Neoplasm;   Colorectal Cancer;   Metastatic Neoplasm
Intervention: Drug: Bevacizumab
33 Completed
Has Results
An Observational Study of Avastin (Bevacizumab) in Patients With Metastatic Breast Cancer
Condition: Breast Cancer
Intervention: Drug: Bevacizumab
34 Terminated Trial of Bevacizumab and Ixabepilone for Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC)
Condition: Non-squamous Non-small Cell Lung Cancer
Interventions: Drug: ixabepilone;   Drug: bevacizumab
35 Active, not recruiting
Has Results
Trastuzumab (Herceptin), Bevacizumab, and Docetaxel (Taxotere) Trial in Stage IV Metastatic Breast Cancer (MBC) Patients
Condition: Breast Cancer
Interventions: Drug: Trastuzumab;   Drug: Bevacizumab;   Drug: Docetaxel
36 Completed Optimized Chemotherapy Followed by Maintenance With Bevacizumab With or Without Erlotinib in Treating Patients With Metastatic Colorectal Cancer That Cannot be Removed by Surgery (DREAM)
Condition: Colorectal Cancer
Interventions: Drug: bevacizumab;   Drug: bevacizumab, erlotinib
37 Completed Phase II Trial of Combination Therapy With Bevacizumab and S-1 in Elderly Patients With Unresectable or Recurrent Colorectal Cancer (BASIC)
Condition: Colorectal Cancer
Intervention: Drug: S-1, Bevacizumab
38 Recruiting Study of Bevacizumab in Combination With Alternating Xeliri and Xelox in Metastatic Colorectal Cancer
Condition: Metastatic Colorectal Cancer
Intervention: Drug: Bevacizumab plus alternating Xelox/Xeliri
39 Completed
Has Results
BEATRICE Study: A Study of Bevacizumab (Avastin) Adjuvant Therapy in Triple Negative Breast Cancer
Condition: Breast Cancer
Interventions: Drug: Bevacizumab;   Drug: Standard adjuvant chemotherapy
40 Completed
Has Results
Study of Oral Topotecan With Bevacizumab for Recurrent Small Cell Lung Cancer
Conditions: Recurrent Small-cell Lung Cancer (SCLC);   Lung Cancer, Small Cell
Intervention: Drug: Oral Hycamtin (topotecan) Capsules + IV Avastin (bevacizumab)

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.